Viewing StudyNCT00043394



Ignite Creation Date: 2024-05-05 @ 11:26 AM
Last Modification Date: 2024-10-26 @ 9:07 AM
Study NCT ID: NCT00043394
Status: COMPLETED
Last Update Posted: 2009-03-12
First Post: 2002-08-08

Brief Title: CPG 7909 Plus Herceptin In Patients With Metastatic Breast Cancer
Sponsor: Pfizer
Organization: Pfizer

Conditions & Keywords Data

Conditions:
Name
Carcinoma Breast
Keywords:
Name View
CpG 7909 subcutaneous injection combination with Herceptin metastatic breast cancer View